Skip to content

Clinical trials

Phase 2 Carcinoma, Non-Small-Cell Lung trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2 Country / region: Czechia Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20063
20085
20092
20111
20132
20142
20151
20171
20181
20191
20201
20222
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated7
Active, not recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Hoffmann-La Roche2
Novartis Pharmaceuticals2
AbbVie1
AbbVie (prior sponsor, Abbott)1
Amgen1
Astellas Pharma Inc1
Bayer1
EMD Serono Research & Development Institute, Inc.1
Eisai Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung27
Lung Neoplasms6
Neoplasm Metastasis4
Colorectal Neoplasms2
Melanoma2
Neoplasms2
Adenocarcinoma1
Adenocarcinoma of Lung1
Biliary Tract Neoplasms1
Brain Neoplasms1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.